TIME Names Paradise Ultrasound System a Best Invention

The renal denervation technology is recognized for its role in treating hypertension with ultrasound energy.

Updated on Oct. 15, 2026 in Stroke

Bold flat-color editorial illustration of a stylized metallic catheter tip, representing medical technology innovation in hypertension treatment.
TIME recognized the Paradise Ultrasound Renal Denervation system as a 2026 Best Invention for its breakthrough approach in treating hypertension. AI Illustration. Upload story photo >

Live Poll

Would you choose a device-based medical procedure over medication to manage your blood pressure?

TIME has selected the Paradise Ultrasound Renal Denervation system as one of its Best Inventions of 2026. The device is used to treat hypertension by targeting sympathetic nerves.

Why it matters

The system offers a new approach to blood pressure management by denervating nerves surrounding the renal arteries. This innovation provides an alternative to traditional medication for patients struggling with hypertension.

The system utilizes a specialized HydroCooling system to circulate sterile water through a balloon catheter, delivering doses of ultrasound energy that last 7 seconds each.

The players

Recor Medical

This Palo Alto-based medical technology company is a subsidiary of Otsuka Medical Devices Co., Ltd.

TIME

This global media organization has published its annual Best Inventions list for 25 years.

The details

Developed by Recor Medical, the system uses ultrasound energy to denervate sympathetic nerves near the renal arteries. The device received approval from the FDA in November 2023 to assist in hypertension treatment.

Timeline

  1. November 2023: FDA approved the Paradise uRDN system.

  2. October 15, 2026: TIME announced the 2026 Best Inventions list.

Health Landscape

This recognition highlights the Paradise uRDN system's role in the evolving medical field of renal denervation. It follows the FDA's 2023 approval of the Paradise uRDN system and underscores the shift toward specialized procedural interventions for chronic conditions.

Patients dealing with hypertension may find this ultrasound-based approach to be a viable alternative to traditional daily medication routines. Individuals interested in this treatment should consult their healthcare provider to determine if they meet the clinical criteria for the procedure.

The takeaway

Innovation in renal denervation represents a significant shift in how chronic hypertension is clinically managed. Patients should discuss new medical technology with their doctors to understand which treatment options are most appropriate for their specific health needs.

Further reading

Learn more about the latest innovations in Stroke management and treatment.

More information

For additional information on this device, visit the Recor Medical company website.

Live Poll

Would you choose a device-based medical procedure over medication to manage your blood pressure?